BrainsWay Investor Relations Material
Latest events
Q2 2025
BrainsWay
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BrainsWay Ltd
Access all reports
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company offers Deep TMS device that uses magnetic current pulses to stimulate the brain safely and painlessly; and Deep TMS Coil that is attached to the dTMS device. It markets the BrainsWay Deep TMS system under the hElios brand name for treating various psychiatric and neurological disorders. Brainsway Ltd. has a license agreement with InSightec, Ltd., which is a co-owner of the exclusive license issued by the Technion-Israel Institute of Technology. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BWAY
Country
🇺🇸 United States